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Prostate cancer (PC) primarily affects elderly men. However, the specific features of cases
diagnosed at younger ages (<65 years) suggest that they may represent a different clinical
subtype. Our aim was to assess this suggestion by contrasting the geographical PC mortal-
ity and hospital admissions patterns in Spain for all ages to those in younger men.
Methods
The Spanish National Institute of Statistics supplied data on PC mortality, hospital admis-
sion, and population data. We estimated the expected town-specific number of deaths and
calculated the standardized mortality ratios. Spatial autoregressive models of Besag-York-
Mollié provided smoother municipal estimators of PC mortality risk (all ages; <65 years). We
computed the provincial age-standardized rate ratios of PC hospital admissions (all men;
<60 years) using Spanish rates as the reference.
Results
A total of 29,566 PC deaths (6% among those <65 years) were registered between 2010–
2014, with three high-mortality risk zones: Northwest Spain; Southwest Andalusia & Gra-
nada; and a broad band extending from the Pyrenees Mountains to the north of Valencia. In
younger men, the spatial patterns shared the high risk of mortality in the Northwest but not
the central band. The PC hospital discharge rates confirmed a North-South gradient but
also low mortality/high admission rates in Madrid and Barcelona and the opposite in South-
west Andalusia.
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Conclusion
The consistent high PC mortality/morbidity risk in the Northwest of Spain indicates an area
with a real excess of risk. The different spatial pattern in younger men suggests that some
factors associated with geographical risk might have differential effects by age. Finally, the
regional divergences in mortality and morbidity hint at clinical variability as a source of ineq-
uity within Spain.
Introduction
Worldwide, prostate cancer (PC) is the second most common tumor among men, with an esti-
mated 1.1 million new cases in 2012[1]. The steep increase in incidence in most countries in
recent decades[2] is generally attributed to the increased detection of indolent prostate neo-
plasms (i.e. use of prostate-specific antigen [PSA] tests as screening tools)[3] a potentially
increased exposure to unknown risk factors[4] accompanied by a sustained decrease in mortal-
ity[5], which, in Spain started in the late 1990s[6]. With an estimated 307,000 deaths in 2012,
PC ranks fifth as the cause of cancer death worldwide among men and third among European
and Spanish men[1,7]. Based on these figures, it is surprising that scarce evidence is available
regarding PC etiology. To date, none of the main well-established risk factors -age, genetic sus-
ceptibility[8], black race, and familial history- are modifiable[4]. The association of this tumor
with other factors such as chemical contaminants[9], diet[10], and medications[11], among
others, is not yet clear.
PC is generally considered a disease of older men. In Spain, the mean patient age at death
in 2015 was 80.6 years[12]. However, an increasing number of new diagnoses occur in men
aged�65 years and the incidence in these age groups is increasing at a higher rate than those
in the older age groups[2]. Some authors have suggested that PC affecting younger men may
constitute a different clinical subtype; in this sense, genetic factors play a more relevant role in
this subgroup[13], and several clinical studies have reported that early-onset advanced-stage
PC has a poorer prognosis and lower survival than those of tumors diagnosed in older age
groups[2,8,14]. As it has also been reported that the effect of some risk factors (i.e. selenium
levels) might be higher among those with increased genetic predisposition[15], the relation-
ship of PC in younger men with external exposures could differ from that of all cases.
Spatial studies and cancer atlases can be useful tools to suggest new etiological hypotheses
for PC based on the geographical variability in the risk of death due to this cause[16], either
related to the differential distribution of possible risk factors or to the variability in diagnostic
and therapeutic strategies among areas. We utilized this strategy to compare the spatial distri-
butions of municipal PC mortality in Spain in all men to the pattern observed for PC mortality
in younger men to identify clues to provide data about early-onset PC. A different mortality
spatial pattern in men under 65 years of age (those probably diagnosed with advanced tumors
a decade earlier[17]) could suggest that some factors associated with the geographical risk
might have differential effects by age group. Finally, we contrasted both patterns with the geo-
graphical distribution of PC-related hospital admissions in the same period to gain insight into
the role that variability in medical practice may play in them.
Material and methods
Fig 1 shows the Spanish regional and provincial administrative distributions to help the reader
to better understand the description of the results.
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Prostate cancer mortality
We mapped the municipal relative risks (RR) of PC mortality (smoothed standardized mortal-
ity ratios) in Spain for the period 2010–2014 and the distributions of posterior probabilities
(PP) of having an RR>1 for a) all ages and b) those younger than 65 years of age. The RRs
were calculated using spatial models including observed and expected cases of PC death at the
municipal level. We also applied this methodology to men�65 years; the resulting map is pre-
sented as Supporting Information (S1 Fig) because of its redundancy with the map for all ages.
Observed and expected cases. The National Statistics Institute (Instituto Nacional de
Estadı́stica-INE) provided data on a) individual death entries between 2010 and 2014 in men
in Spain corresponding to PC (International Classification of Diseases, 10th Revision: C61),
broken down by municipality (n = 8,097), and b) the Spanish municipal roll male population
data by town and age (18 age groups) in 2012, the midpoint of the study period. We calculated
the numbers of expected cases by multiplying the overall Spanish age-specific mortality rates
for the five-year study period by each town’s person-years (2012 population�5). Afterward,
standardized mortality ratios (SMRs) were computed as the ratios of the observed to the
expected deaths.
Municipal relative risks (RRs). Municipal smoothed SMRs (RRs) were calculated using
the conditional autoregressive model proposed by Besag, York and Mollié[18], based on fitting
Fig 1. Regional and provincial administrative distributions within Spain.
https://doi.org/10.1371/journal.pone.0210980.g001
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a Poisson spatial model with observed cases as the dependent variable, expected cases as an off-
set, and two types of random effect terms: a) municipal contiguity (spatial term hi); and b)
municipal heterogeneity (bi). The model takes the following form:
Oi � PoissonðEiliÞ
logðliÞ ¼ aþ hi þ bi
i ¼ 1 : 8097 municipalities
Where λi is the RR in area i; Oi is the number of deaths in area i; α is the intercept quantifying
the average mortality rate in all municipalities; and Ei is the expected number of cases. The
models were fitted with “Integrated nested Laplace approximations” [19] (INLAs) as the tool
for Bayesian inference, using the R-INLA package with the option of a simplified Laplace esti-
mation of the parameters and the default specification for the distribution of the hyper-param-
eters in all the models. The spatial term (hi) is modelled using a conditional autoregressive
structure and the heterogeneity term (bi), which corresponds to the unstructured residual, is
modelled using an exchangeable prior. The criterion of contiguity was the adjacency of the
municipal boundaries according to official INE maps.
Prostate cancer morbidity
For the study of the geographical distribution of prostate cancer patient admissions, we
decided to complement the 5-year period depicted in the mortality data (2010–2014) with the
previous one (2005–2009) and to move the age limit to 60. We wanted to look at the same
cohort of men in mortality and morbidity data; as relative survival in Spain for PC is close to
85% at 5 years[20], any man dead from PC would usually be treated in the hospital at least five
or ten years before (i.e. 5–10 years younger). We used the Hospital Morbidity Survey[21] car-
ried out by the INE to determine the number of hospital admission records in men having PC
as main diagnosis at discharge (ICD9-CM: 185; ICD10: C61), as well as the corresponding
population figures for the periods 2005–2009 and 2010–2014, broken down by province
(n = 50, excluding Ceuta and Melilla cities due to their small populations) and age (18 age
groups). We applied the corresponding elevation factors and calculated age-adjusted discharge
rates per province for all patients as well as for those under 60 years at admission in each quin-
quennium; afterward, we mapped the admission rate ratios per province for the same strata,
using the Spanish rates as the reference. The map corresponding to men> = 60 years is
included as Supporting Information (S2 Fig).
R software was used to create maps and to perform all the previously mentioned statistical
analyses.
Results
A total of 29,566 deaths due to PC (6% in men younger than 65 years old) were reported in
2010–2014. The mortality patterns are shown in Fig 2, which presents the spatial distributions
of the risk of death due to PC for all PC cases, while Fig 3 shows this information for PC deaths
in men <65 years of age. Each figure includes two maps: one depicting the municipal risk of
death due to PC compared to the average in Spain and another representing the probability for
each town of having an excess of risk (RR>1).
For all ages, municipal RR ranked from 0.46 to 1.54, and three areas could be considered
high-mortality risk zones: a) northwest Spain, that is, the Atlantic and Cantabrian coasts, mainly
Galicia, Asturias, and the Basque Country; b) southwest of Andalusia and Granada; and c) a
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long band crossing from the Pyrenees Mountains, through Aragon, to Castellon and the north
of Valencia on the Mediterranean coast. In contrast, lower risks than the average of Spain were
observed in Madrid, in the coastal areas of Tarragona, Barcelona, Alicante, and Murcia (Fig 2).
The geographical pattern in younger men (Fig 3) was less pronounced than the one
observed for all men, with RR ranging from 0.88 to 1.24. In this case we also observed higher
Fig 2. Prostate cancer mortality in Spain between 2010 and 2014 (all men). Municipal distributions of the relative
risks of death (A) and posterior probabilities of having a relative risk greater than 1 (B).
https://doi.org/10.1371/journal.pone.0210980.g002
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risk areas in the northwest, mainly in Galicia and Asturias, and southwest Spain (Huelva), but
there was a striking difference with the pattern seen in Fig 2, including the absence of risk in
Aragon, Castellon, Valencia, and in the Basque Country.
The risks of hospital admissions due to PC are depicted in Fig 4. For the period 2005–2009
rate ratios varied between 0.43–1.92 in all cases and between 0.36–1.57 in men <60 years,
Fig 3. Prostate cancer mortality in Spain between 2010 and 2014 (men<65 years). Municipal distributions of the
relative risks of death (A) and posterior probabilities of having a relative risk greater than 1 (B).
https://doi.org/10.1371/journal.pone.0210980.g003
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while for 2010 to 2014 period, they ranged between 0.46–1.70 for all men and between 0.47–
1.58 in younger men. Both maps presented a similar pattern, and showed an even clearer gen-
eral north/south gradient than that observed for mortality rates. Thus, hospitals in the north-
west provinces (Galicia, Asturias, and the Basque Country) had higher PC-related age-
adjusted admissions rates than the average rate in Spain in both young and older patients;
however, Extremadura, Andalusia (including the southwestern portion), and Castile-La Man-
cha had low rates of hospital admissions. Furthermore, there were slight excesses of hospital
discharges in Madrid and Barcelona, which are areas with low mortality risks.
Discussion
The spatial distribution of PC mortality by municipality in the period 2010–2014 in Spain
showed high-risk zones in the north and the west, in line with period 2004–2008 [22], although
with a more marked excess of mortality in the southwest of Andalusia. However, the most
noteworthy result from the present study is the contrasting mortality patterns observed
between all ages and those of younger men (<65 years) in the eastern part of the country.
Based on the survival figures for PC in Spain[22], our map of mortality due to PC before 65
years of age likely shows the spatial distribution of the risk of dying in men diagnosed with
advanced tumors a decade earlier. PC tumors in men under 55 years of age are more likely to
have been detected through PSA screening and to be of low grade; consequently, these patients
have equivalent or even higher survival rates than the rates in older ones[23]. However, the
subgroup of younger men with high-grade or metastatic tumors has a higher cause-specific
mortality rate than those among men diagnosed at an older age[14,23]; this finding suggests
Fig 4. Provincial rate ratios of age-standardized hospital admissions in Spain between 2005 and 2014 with prostate cancer as the main diagnosis
by 5-year period for all men and those<60 years of age.
https://doi.org/10.1371/journal.pone.0210980.g004
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that these tumors might constitute a different clinical entity[8,13] with specific biological fea-
tures[24,25]. Our study supports the hypothesis that PC in younger men may have its own
specificities, at least from an epidemiological point of view, as it showed a clear difference
among spatial mortality patterns depending on age: for all cases, there was an excess risk in the
eastern band from the Pyrenees to the north of the Valencian Community (Castellon), as well
as in the Basque Country, which was absent in those who died before 65 years of age. These
diverse spatial mortality patterns might derive from differences in a) incidence (variability in
genetic predisposition, diagnostic strategies, or exposure to environmental causes); b) lethality
(regional differences in the availability or quality of medical treatment or in the exposure to
promoter risk factors), and c) death certificate quality.
Regarding genetic factors, genome-wide association studies (GWAS) have identified over
100 single nucleotide polymorphisms associated with the development of PC[26] and a family
history of PC doubles the risk of disease development in first-degree relatives[27]; these factors
appear to be associated with an increased risk among men under 65 years of age[28]. Unfortu-
nately, there is no information about the geographical variability of genetic PC susceptibility;
however, in a preliminary analysis of a PC polygenic risk score in the Spanish multi-province
MCC-Spain PC case-control study, we found quite small differences among regions, suggest-
ing that this factor may not be very relevant in the geographical diversity of risk.
A possible contributor to the spatial discrepancy by age, more related to variability in clini-
cal practice, may be the effect of PC screening strategies on mortality statistics. In Spain, PC is
among the well-certified tumors in death registries[29]; however, some authors have reported
that the diagnosis of prostate cancer due to PC screening can lead practitioners to report more
deaths as due to this cause (attribution bias)[30], an effect that is stronger in older men[31].
Thus, those areas more prone to PSA use would have a higher risk of PC-attributed death in all
men, which would be less apparent when only younger men are considered. Unfortunately, we
have no information regarding the date of introduction of PSA testing in Spain, or on its
spread or prevalence across the country, which could help to test its effect on these geographi-
cal patterns[32].
PC is also a tumor with higher variability in its indication and types of treatment[33]. This
is due to a combination of different social, organizational, and clinical factors, which may
strongly influence the spatial distribution of PC risk. Even though Spaniards have universal
public health coverage, the available data indicate that the rate of PC surgical interventions is
higher in areas with better socioeconomic indicators[34]. The mortality risks in younger men
present a higher homogeneity. This is probably associated with the low number of deaths in
the younger group, but another plausible contributing explanation is a lower variability in the
treatment of advanced cases in young patients, which usually implies a more aggressive clinical
approach than that in elderly men[13] due to their a priori higher life expectancy.
An alternative hypothesis to explain the different spatial patterns by age could be the pres-
ence of environmental agents in these areas for which a sustained, chronic exposure could
induce PC and which would be more likely to occur at advanced ages. Among the candidate
environmental pollutants is arsenic, classified by the International Agency for Research on
Cancer (IARC) as a possible carcinogen for the prostate[35]. In a recent study carried out by
our group, we observed a significant association between topsoil levels of this carcinogen and
total PC mortality in 1999–2008[36]. The arsenic soil level was higher in the northwest and
southwest regions of Spain, as well as in the area of Castellon and south of Aragon. Also pres-
ent in soil is selenium; its levels modulate selenium concentration in food, the main source of
exposure in humans. According to observational studies, selenium is a putative protective fac-
tor for PC[37], although this association was not corroborated by the SELECT clinical trial
[38]. In Spain, the topsoil concentrations of selenium are highly variable, but the highest levels
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are found in the northwest regions, including Galicia, the Valencian Community and, less notice-
ably, in the southwestern parts of the country[39], all areas with high PC mortality. Our data do
not seem to support the preventive role of selenium exposure, at least at an ecological level.
Pesticides, which have also been related to PC occurrence[40,41], could also be involved in
this pattern. In recent years (1999–2014), the use of pesticides in Aragon has increased by
22.6%[42]. Valencian Community and Andalusia are also among the regions with the highest
use of pesticides, comprising around 13% and 30%, respectively, of the country’s pesticide con-
sumption[42]. Therefore, further research in this regard could be of great interest.
Among other possible factors that might help us to understand the distribution of PC risk,
diet has always been a candidate, as Spain has a marked dietary diversity among regions. The
World Cancer Research Fund (WCRF) report suggests that dairy products and calcium-rich
diets might increase the risk of PC[43]. Milk consumption in 2008 was higher in the north-
western parts of the country (Asturias, Cantabria, and Basque Country) as well as in Extrema-
dura and Castile-Leon, and very low in Andalusia, Catalonia, and Murcia[44]. In contrast,
Galicia, Cantabria, Basque Country, and Castile-Leon are among the regions with the highest
consumption of fresh fish[44], which has been associated with lower PC mortality[45]. The
impact of diet on PC mortality may be more accurately studied if global dietary patterns are
considered[10].
The North-West of Spain (Galicia and Asturias) deserve a specific comment. The excess of
mortality in this part of the country among young men and all men, together with the consis-
tently higher rates of hospital admissions in these areas, point to a real excess of PC risk. Obe-
sity may play a role in this finding: both regions lead the adult overweight rate rankings[46]
and, according to the WCRF[43], body fatness is likely to be associated with advanced-stage
prostate tumors[47], although the mechanisms remain unclear. However, weight excess is also
very high in Extremadura and Castile-La Mancha, where the risk of death due to PC was not
especially striking[48].
The two provinces that include the main cities of Spain, Madrid and Barcelona, also merit
attention: these regions presented very low mortality risks in both mortality maps, in contrast
to their higher than average rates of hospital admissions; the contrary was observed in Huelva
(west Andalusia), with high mortality and low admission rates. These discrepancies require
additional study in more detail to evaluate the differences in the healthcare patterns among
regions.
One of the strengths of this work is the novel approach to assess the distribution of PC mor-
tality by separately evaluating the risks in the younger cases as well as the combined use of spa-
tial mortality and morbidity that provides a more complete picture of PC risk in Spain.
However, this report also has limitations inherent to all ecological studies. This kind of
approaches are useful to develop new hypothesis, but the lack of age-specific geographical dis-
tributions of the possible risk factors (i.e. diet or arsenic exposure) precludes the possibility of
testing for specific associations. Also, as we have mentioned, there might be variability in
death certificate coding among areas; however, the coordinator role of the National Institute
of Statistics and the quality control process at regional level probably attenuate the effect of
this a source of error. Finally, the low number of deaths in the case of prostate cancer under 65
year old might lead to potentially oversmoothed risk maps. For this reason, the models have
been parameterized according to the recommended specifications to minimize bias[19]
Conclusions
In conclusion, the consistently high PC mortality and morbidity risk in the northwest of Spain
point to a higher risk of PC in this region. The different spatial pattern in men under 65 years
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of age suggests that some factors associated with the geographical risk might have differential
effects by age group. Finally, the divergences in mortality and morbidity patterns in some
regions, such as Madrid, Barcelona, or Huelva, indicate that variability in the patterns of care
could be a relevant source of inequity among Spanish regions.
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